Actively Recruiting
Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
Led by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Updated on 2018-03-06
1200
Participants Needed
1
Research Sites
791 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores. There is a need for additional studies. The Center for Comprehensive Care of Patients with Diabetes (CAIPaDi) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services.
CONDITIONS
Official Title
Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 18 and 70 years old
- Have a diagnosis of type 2 diabetes within the last five years
- Have family support
- Be free of disabling diabetes complications
You will not qualify if you...
- Have advanced diabetes complications such as ischemic heart disease, severe heart failure (NYHA III-IV), advanced kidney failure (KDOQI stage 3 or higher), amputations, stroke, gastroparesis, or muscle atrophy
- Have type 1 diabetes, gestational diabetes, or diabetes related to genetic syndromes or hyperlabile diabetes
- Have life-limiting conditions such as malignant tumors
- Have advanced cognitive impairment or serious psychiatric disorders
- Smoke, have alcoholism, or illegal drug dependence
- Have conditions requiring surgery soon or that prevent moderate physical activity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Ciencias Medicas y Nutricion
Mexico City, Mexico City, Mexico, 14000
Actively Recruiting
Research Team
S
Sergio Hernández, MD
CONTACT
C
Carlos A Aguilar-Salinas, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here